ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver cirrhosis"

  • 2018 American Transplant Congress

    Intestinal Microbiome Diversity is Associated with Liver Disease Etiology and Predicts Post-Liver Transplant Mortality

    E. Verna, M. Annavajhala, M. Nenad, R. Brown, S. Sullivan, G. Korakani, M. Gidins, S. Khan, A. Gomez-Simmonds, A-.C. Uhlemann.

    Medicine, Columbia University, New York, NY.

    Background: Dysbiosis of the intestinal microbiome is common among patients with decompensated liver disease and has been associated with disease progression as well as life-threatening…
  • 2018 American Transplant Congress

    Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients

    R. Rosenblatt,1 N. Shen,1 Z. Tafesh,1 B. Fortune,1 K. Halazun,1 A. Jesudian.1

    1Medicine/Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY; 2Surgery, Weill Cornell Medicine, New York, NY.

    IntroductionThe characteristics of liver transplant (LT) recipients have evolved over time as centers adapt to allocation policy changes and the shifting demographics of the US…
  • 2018 American Transplant Congress

    Health and Economic Disparities in Waitlist Access and Liver Distribution Policy

    R. Lynch,1 K. Ross,1 T. Pearson,1 D. Goldberg,2 R. Patzer.1

    1Surgery, Emory University, Atlanta, GA; 2Hepatology, University of Pennsylvania, Philadelphia, PA.

    Background:Sociodemographic disparities compound mortality on the liver transplant waitlist, but the relevance of waitlist disparities to mortality and access among the general population remains unclear.Methods:…
  • 2018 American Transplant Congress

    Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for the Treatment of Medically Refractory Hepatic Encephalopathy (HE) in Patients with ESLD and Significant Portal-Venous Shunting

    N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

    Liver and Pancreas Transplantation, Dumont-UCLA Liver Transplant Center, Los Angeles, CA.

    Background: Patients with medical refractory HE represent a challenging group of patients. Plagued by repeated hospitalizations, long lengths of stay (LOS) and high healthcare costs,…
  • 2018 American Transplant Congress

    MELD-Na Score Based Liver Allocation: Hyponatremia is No Longer a Risk Factor for Waitlist Mortality

    S. Nagai,1 L. Chau,1 M. Safwan,1 R. Schilke,1 M. Rizzari,1 K. Collins,1 A. Yoshida,1 M. Abouljoud,1 D. Moonka.2

    1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 2Gastroenterology, Henry Ford Hospital, Detroit, MI.

    Background: Hyponatremia is associated with an increased risk of liver transplant (LT) waitlist mortality. The aim of this study was to compare waitlist outcomes between…
  • 2018 American Transplant Congress

    Contemporary Practice Patterns & Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement: A Multicenter US Experience of 1,146 Patients

    J. Boike,1 J. Ge,5 M. German,3 N. Jest,2 G. Morelli,2 E. Spengler,3 A. Said,3 A. Lee,3 A. Hristov,3 K. Kolli,4 J. Lai,4 A. Desai,5 S. Junna,5 B. Pokhrel,5 T. Couri,6 S. Paul,6 N. Christian-Miller,7 C. Frenette,7 M. Laurito,8 E. Verna,8 U. Rahim,9 A. Goel,9 A. Das,1 S. Pine,1 D. Gregory,1 L. VanWagner.1

    1Gastro & Hep, Northwestern, Chicago; 2Gastro & Hep, Univ of Florida, Gainesville; 3Gastro & Hep, Univ of Wisconsin, Madison; 4Med, Gastro & Hep, Radiology, UCSF, San Francisco; 5Med, Gastro & Hep, Univ of Arizona, Tucson; 6Med, Gastro & Hep, Univ of Chicago, Chicago; 7Gastro & Hep, Scripps Clinic, La Jolla; 8Gastro & Hep, Columbia, New York; 9Gastro & Hep, Stanford, Palo Alto.

    Background: TIPS is effective for treating complications of portal hypertension. Historic, single center data suggest poor outcomes for MELD scores >15. We assessed contemporary outcomes…
  • 2018 American Transplant Congress

    Advanced Liver Care and Salvage Transplantation Improves Outcomes for Patients with Cirrhosis Requiring Abdominal General Surgical Procedures

    D. Milgrom,1 N. Valsangkar,1 J. Kays,1 T. Liang,1 J. Butler,1 C. Kubal,1 M. Maluccio,1 A. Tector,2 L. Koniaris.1

    1Department of Surgery, Indiana University School of Medicine, Indianapolis, IN; 2Department of Transplant Surgery, University of Alabama School of Medicine, Birmingham, AB.

    Introduction: Historically, abdominal general surgical procedures on cirrhotic patients carry up to an 80% mortality rate. We hypothesized outcomes of cirrhotic patients requiring abdominal surgical…
  • 2018 American Transplant Congress

    Risk Factors of De Novo Malignancies after Liver Transplantation

    M. Altieri,1 O. Seree,2 J. Dumortier,3 GREF2 Groupe de Recherche Français en Greffe de Foie.

    1Service d'HepatoGastroenterologie, Nutrition et Oncologie Digestive, CHU de Caen, Caen, France; 2Réseau Régional de Cancérologie Onco-Basse-Normandie, Herouville Saint-Clair, France; 3Service d'HepatoGastroenterologie, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France.

    De novo malignancies after liver transplantation (LT) are one of the leading causes of late mortality, with a reported risk of malignancies twice as high…
  • 2018 American Transplant Congress

    Transplant Trends in Young Adults: Silent Alcohol Epidemic

    N. Kemmer,2 N. Bozanich,1 S. Agrawal,2 C. Albers,2 R. Syed,2 A. Alsina.2

    1Gastroenterology, USF, Tampa; 2Transplant Hepatology, Tampa General Medical Group, Tampa.

    With the introduction of effective antiviral therapy for HCV, there is a paradigm shift in liver disease with a decline in HCV but a parallel…
  • 2018 American Transplant Congress

    Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life

    S. Elwir,1 A. Warren,1 G. Saracino,1 S. Asrani,1 T. Elliott,2 G. Klintmalm.1

    1Baylor University Medical Center, Dallas, TX; 2Department of Educational Psychology, Texas A&M University, College Station, TX.

    Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 14
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences